Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Feb;7(2):183–187. doi: 10.1111/j.1365-2125.1979.tb00919.x

Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.

G J Davies, P K Marrott, J R Muir
PMCID: PMC1429441  PMID: 760751

Abstract

1 The haemodynamic and electrocardiographic effects of intravenous disopyramide were studied in fifteen patients with acute myocardial infarction. 2 Five minutes after drug injection a rise in heart rate, aortic mean and diastolic pressures and systemic vascular resistence was noted which persisted for at least 30 min. A small increase in pulmonary arterial diastolic pressure (mean = 1.5 mm Hg) occurred at 5 min only and no significant change of cardiac output was found throughout the period of the study (1 h). 3 Surface electrocardiograms revealed transient prolongation of the P-R interval and a sustained increase in the QTc interval. 4 The haemodynamic changes suggest an anticholinergic effect of the drug. There was no definite evidence of a negative inotropic effect in this study, however, these peripheral haemodynamic measurements might not have revealed a modest negative inotropic effect. 5 The electrocardiographic changes are similar to those previously reported in normals and in patients without acute myocardial infarction.

Full text

PDF
186

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERRY J. N., THOMPSON H. K., Jr, MILLER D. E., McINTOSH H. D. Changes in cardiac output, stroke volume, and central venous pressure induced by atropine in man. Am Heart J. 1959 Aug;58(2):204–213. doi: 10.1016/0002-8703(59)90337-0. [DOI] [PubMed] [Google Scholar]
  2. Falicov R. E., Resnekov L. Relationship of the pulmonary artery end-diastolic pressure to the left ventricular end-diastolic and mean filling pressures in patients with and without left ventricular dysfunction. Circulation. 1970 Jul;42(1):65–73. doi: 10.1161/01.cir.42.1.65. [DOI] [PubMed] [Google Scholar]
  3. MOKLER C. M., VAN ARMAN C. G. Pharmacology of a new antiarrhythmic agent, gamma-diisopropyl-amino-alpha-phenyl-alpha-(2-pyridyl)-butyramide (SC-7031). J Pharmacol Exp Ther. 1962 Apr;136:114–124. [PubMed] [Google Scholar]
  4. Marrott P. K., Ruttley M. S., Winterbott J. T., Muir J. R. Disopyramide: a study of its acute electrophysiological and haemodynamic effects [proceedings]. Br J Clin Pharmacol. 1975 Aug;2(4):373P–373P. [PubMed] [Google Scholar]
  5. Mathur P. P. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate. Am Heart J. 1972 Dec;84(6):764–770. doi: 10.1016/0002-8703(72)90069-5. [DOI] [PubMed] [Google Scholar]
  6. Selvini A. La profilassi delle aritmie nell'infarto miocardico mediante disopiramide. Minerva Med. 1970 Sep 5;61(71 Suppl):3774–3776. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES